Literature DB >> 32216970

SPECC1L-ALK: A novel gene fusion response to ALK inhibitors in non-small cell lung cancer.

Li Ma1, Quan Zhang1, Yujie Dong2, Haoyang Li1, Jinghui Wang3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32216970     DOI： 10.1016/j.lungcan.2020.03.017

Source DB:  PubMed          Journal:  Lung Cancer        ISSN： 0169-5002            Impact factor:   5.705


× No keyword cloud information.
  3 in total

1.  Coexistence of a novel CCNY-ALK and ATIC-ALK double-fusion in one patient with ALK-positive NSCLC and response to crizotinib: a case report.

Authors:  Xuan Wu; Hanqiong Zhou; Zhen He; Zhe Zhang; Wen Feng; Jiuzhou Zhao; Haiyang Chen; Shuai Wang; Wei Wang; Qiming Wang
Journal:  Transl Lung Cancer Res       Date:  2020-12

2.  Case Report: A Novel Non-Reciprocal ALK Fusion: ALK-GCA and EML4-ALK Were Identified in Lung Adenocarcinoma, Which May Respond to Alectinib Adjuvant-Targeted Therapy.

Authors:  Xiaoqian Zhai; Qiang Wu; Dan Pu; Liyuan Yin; Weiya Wang; Daxing Zhu; Feng Xu
Journal:  Front Oncol       Date:  2022-01-05       Impact factor: 6.244

3.  Cytospin-A Regulates Colorectal Cancer Cell Division and Migration by Modulating Stability of Microtubules and Actin Filaments.

Authors:  Fan Fan; Jason Roszik; Ling Xia; Susmita Ghosh; Rui Wang; Xiangcang Ye; David Hawke; Lee M Ellis; Rajat Bhattacharya
Journal:  Cancers (Basel)       Date:  2022-04-14       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.